Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$12.08
Net Income/Share$-0.34
Operating CF/Share$1.27
Free CF/Share$1.25
Cash/Share$4.99
Book Value/Share$18.61
Tangible Book/Share$5.45
Equity/Share$18.61
Interest Debt/Share$0.56
CapEx/Share$0.02
Dividend/Share$0.00
Valuation
Market Cap$2.76B
Enterprise Value$2.64B
P/E Ratio-142.07P/S Ratio4.05P/OCF Ratio37.79
P/FCF Ratio39.03
P/B Ratio2.59P/TB Ratio2.59
EV/Sales3.88EV/EBITDA44.09
Graham Valuation
Graham Number--
Graham Net-Net$1.40
Profitability
Earnings Yield-0.70%FCF Yield2.56%ROE-1.83%ROIC-3.13%Return on Tangible Assets-2.82%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF1.56%
CapEx/Revenue0.16%
CapEx/Depreciation0.01
SBC/Revenue4.55%
SG&A/Revenue11.72%
R&D/Revenue15.71%
Liquidity & Solvency
Debt/Equity0.03Debt/Assets0.02Debt/Market Cap0.01
Net Debt/EBITDA-2.00
Current Ratio1.80Interest Coverage0.00xIncome Quality-3.76Efficiency
Days Sales Outstanding92 days
Days Payables Outstanding370 days
Days Inventory271 days
Receivables Turnover3.98x
Payables Turnover0.99x
Inventory Turnover1.35x
Capital Structure
Tangible Assets$307.11M
Working Capital$263.26M
Invested Capital$1.02B
Intangibles/Assets52.30%